Curcumin Tops Five Plant Compounds in Lab Tests on Cancer Cells
Researchers compared curcumin, berberine, biochanin A, cucurbitacin E, and CAPE on fibrosarcoma cells and healthy muscle cells. All five compounds disrupted cancer-cell energy production and pushed many malignant cells into a non-dividing state, with curcumin showing the strongest effect. Curcumin also had a comparatively favorable safety profile, whereas some other compounds caused greater toxicity.
The study came from Wroclaw Medical University and the University of Wroclaw and examined five plant-derived substances: curcumin, berberine, biochanin A, cucurbitacin E, and CAPE, which occurs in propolis. Researchers compared their effects on fibrosarcoma cells and healthy muscle cells, focusing on NF-kB signaling, a pathway involved in inflammation, metabolism, survival, and aging.
Mitochondrial energy production was impaired, with ATP falling more sharply in cancer cells than healthy muscle cells. Berberine, cucurbitacin E, and CAPE increased PINK1/PARKIN-dependent mitophagy in fibrosarcoma cells. All compounds induced senescence; curcumin was strongest, raising senescent cancer cells from about 16.5% to over 75%.
The findings could draw attention from cancer researchers, patients, and clinicians considering adjunctive or preventive options, though cell-based results may not translate into clinical benefit. Because these compounds are plant-derived and sometimes sold as supplements, consumers may wonder about their use; safety and effectiveness in people may still be uncertain. The work could steer future studies toward selective metabolic or senescence-targeting approaches, while cautioning that stronger activity in cancer cells may not imply better human outcomes.